Home5VB • FRA
add
Nykode Therapeutics ASA
Previous close
€0.087
Day range
€0.089 - €0.089
Year range
€0.086 - €0.46
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 198.00K | -66.10% |
Operating expense | 6.88M | -44.41% |
Net income | 859.00K | 111.63% |
Net profit margin | 433.84 | 134.29% |
Earnings per share | 0.00 | 100.00% |
EBITDA | -6.49M | 44.05% |
Effective tax rate | 172.80% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 69.99M | -48.74% |
Total assets | 111.61M | -37.95% |
Total liabilities | 8.84M | -68.19% |
Total equity | 102.77M | — |
Shares outstanding | 326.55M | — |
Price to book | 0.28 | — |
Return on assets | -12.93% | — |
Return on capital | -13.74% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | 859.00K | 111.63% |
Cash from operations | -7.90M | 39.79% |
Cash from investing | 1.02M | -59.67% |
Cash from financing | -32.60M | -10,913.51% |
Net change in cash | -36.25M | -236.81% |
Free cash flow | -5.48M | 31.38% |
About
Founded
2006
Website
Employees
68